Elixxer Ltd
Elixxer Ltd. does not have significant operations. The company invests in the cultivation and production of cannabis products. Elixxer Ltd. is based in Montreal, Canada.
Elixxer Ltd (ELIXF) - Total Assets
Latest total assets as of September 2025: $2.17 Million USD
Based on the latest financial reports, Elixxer Ltd (ELIXF) holds total assets worth $2.17 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Elixxer Ltd - Total Assets Trend (2014–2024)
This chart illustrates how Elixxer Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Elixxer Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Elixxer Ltd's total assets of $2.17 Million consist of 3.3% current assets and 96.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 1.0% |
| Accounts Receivable | $50.32K | 2.4% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Elixxer Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Elixxer Ltd's current assets represent 3.3% of total assets in 2024, a decrease from 100.0% in 2014.
- Cash Position: Cash and equivalents constituted 1.0% of total assets in 2024, down from 88.1% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 2.4% of total assets.
Elixxer Ltd Competitors by Total Assets
Key competitors of Elixxer Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Elixxer Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Elixxer Ltd generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Elixxer Ltd is currently not profitable relative to its asset base.
Elixxer Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 0.00 | 0.14 |
| Quick Ratio | 0.01 | 0.00 | 0.14 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-17.04 Million | $ -14.44 Million | $ -13.73 Million |
Elixxer Ltd - Advanced Valuation Insights
This section examines the relationship between Elixxer Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.45 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -24.0% |
| Total Assets | $2.13 Million |
| Market Capitalization | $10.66K USD |
Valuation Analysis
Below Book Valuation: The market values Elixxer Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Elixxer Ltd's assets decreased by 24.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Elixxer Ltd (2014–2024)
The table below shows the annual total assets of Elixxer Ltd from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.13 Million | -23.99% |
| 2023-12-31 | $2.81 Million | -13.02% |
| 2022-12-31 | $3.23 Million | -67.29% |
| 2021-12-31 | $9.87 Million | -17.78% |
| 2020-12-31 | $12.00 Million | -29.54% |
| 2019-12-31 | $17.03 Million | -19.02% |
| 2019-09-30 | $21.03 Million | +71.66% |
| 2018-12-31 | $12.25 Million | +647.33% |
| 2017-12-31 | $1.64 Million | -65.32% |
| 2016-12-31 | $4.73 Million | +1716.20% |
| 2016-06-30 | $260.25K | -96.89% |
| 2015-12-31 | $8.37 Million | +2949.15% |
| 2014-12-31 | $274.38K | -- |